Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands.
Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
J Nucl Med. 2018 Jun;59(6):986-992. doi: 10.2967/jnumed.117.205575. Epub 2018 Feb 15.
The potential of receptor-mediated fluorescence-based image-guided surgery tracers is generally linked to the near-infrared emission profile and good-manufacturing-production availability of fluorescent dyes. Surprisingly, little is known about the critical interaction between the structural composition of the dyes and the pharmacokinetics of the tracers. In this study, a dual-modality tracer design was used to systematically and quantitatively evaluate the influence of elongation of the polymethine chain in a fluorescent cyanine dye on the imaging potential of a targeted tracer. As a model system, the integrin marker αβ was targeted using arginylglycylaspartisc acid [RGD]-based vectors functionalized with a In-diethylenetriaminepentaacetic acid (DTPA) chelate and a fluorescent dye: (Cy3-(SO)methyl-COOH [emission wavelength (λ), 580 nm], Cy5-(SO)methyl-COOH [λ, 680 nm], or Cy7-(SO)methyl-COOH [λ, 780 nm]). Tracers were analyzed for differences in photophysical properties, serum protein binding, chemical or optical stability, and signal penetration through tissue. Receptor affinities were evaluated using saturation and competition experiments. In vivo biodistribution (SPECT imaging and percentage injected dose per gram of tissue) was assessed in tumor-bearing mice and complemented with in vivo and ex vivo fluorescence images obtained using a clinical-grade multispectral fluorescence laparoscope. Two carbon-atom-step variations in the polymethine chain of the fluorescent cyanine dyes were shown to significantly influence the chemical and photophysical characteristics (e.g., stability, brightness, and tissue penetration) of the hybrid RGD tracers. DTPA-Cy5-(SO)methyl-COOH-c[RGDyK] structurally outperformed its Cy3 and Cy7 derivatives. Radioactivity-based evaluation of in vivo tracer pharmacokinetics yielded the lowest nonspecific uptake and highest tumor-to-background ratio for DTPA-Cy5-(SO)methyl-COOH-c[RGDyK] (13.2 ± 1.7), with the Cy3 and Cy7 analogs trailing at respective tumor-to-background ratios of 5.7 ± 0.7 and 4.7 ± 0.7. Fluorescence-based assessment of tumor visibility revealed a similar trend. These findings underline that variations in the polymethine chain lengths of cyanine dyes have a profound influence on the photophysical properties, stability, and in vivo targeting capabilities of fluorescent imaging tracers. In a direct comparison, the intermediate-length dye (Cy5) yielded a superior c[RGDyK] tracer, compared with the shorter (Cy3) and longer (Cy7) analogs.
基于受体的荧光引导手术示踪剂的潜力通常与近红外发射谱和荧光染料的良好生产规范可用性有关。令人惊讶的是,人们对染料的结构组成与示踪剂的药代动力学之间的关键相互作用知之甚少。在这项研究中,设计了一种双模式示踪剂,以系统地和定量地评估荧光菁染料中聚甲川链的伸长对靶向示踪剂成像潜力的影响。作为模型系统,使用带有精氨酸-甘氨酰-天冬氨酸 [RGD]基载体的整合素标记物 αβ,该载体用铟-二乙三胺五乙酸(DTPA)螯合物和荧光染料功能化:(Cy3-(SO)甲基-COOH [发射波长(λ),580nm],Cy5-(SO)甲基-COOH [λ,680nm]或 Cy7-(SO)甲基-COOH [λ,780nm])。分析示踪剂在光物理性质、血清蛋白结合、化学或光学稳定性以及组织穿透信号方面的差异。使用饱和和竞争实验评估受体亲和力。在荷瘤小鼠中评估体内生物分布(SPECT 成像和每克组织的注射剂量百分比),并使用临床级多光谱荧光腹腔镜获得体内和体外荧光图像进行补充。荧光菁染料中聚甲川链的两个碳原子步变化显着影响了杂交 RGD 示踪剂的化学和光物理特性(例如稳定性、亮度和组织穿透性)。DTPA-Cy5-(SO)甲基-COOH-c[RGDyK]在结构上优于其 Cy3 和 Cy7 衍生物。基于放射性的体内示踪剂药代动力学评估得出 DTPA-Cy5-(SO)甲基-COOH-c[RGDyK]的最低非特异性摄取和最高肿瘤与背景比(13.2±1.7),Cy3 和 Cy7 类似物的肿瘤与背景比分别为 5.7±0.7 和 4.7±0.7。肿瘤可见性的荧光评估也显示出类似的趋势。这些发现强调了菁染料中聚甲川链长度的变化对荧光成像示踪剂的光物理性质、稳定性和体内靶向能力有深远的影响。在直接比较中,与较短的(Cy3)和较长的(Cy7)类似物相比,中等长度的染料(Cy5)产生了更好的 c[RGDyK]示踪剂。